Results 221 to 230 of about 452,213 (327)

Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
ABSTRACT The hormone receptor (HR)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer subtype accounts for most early and metastatic breast cancer (MBC) cases. HR‐positive/HER2‐negative MBC is characterized by a relatively prolonged, although variable, disease course and substantial intertumoral and intratumoral ...
Akshara Singareeka Raghavendra   +5 more
wiley   +1 more source

Sentinel Lymph Node Biopsy in Low-Risk Breast Cancer in Patients ≥ 70 Years: How Wisely are We Choosing? [PDF]

open access: yesAnn Surg Oncol
Tortorello GN   +9 more
europepmc   +1 more source

Sentinel lymph node assessment in endometrial cancer: a systematic review and meta‐analysis

open access: yesAmerican Journal of Obstetrics and Gynecology, 2017
Anna Jo Bodurtha Smith   +2 more
semanticscholar   +1 more source

Sentinel Lymph Node Biopsy Versus Elective Neck Dissection in Carcinoma of the Tongue and Floor of the Mouth. [PDF]

open access: yesCancers (Basel)
Naegeli-Pullankavumkal C   +6 more
europepmc   +1 more source

Sentinel lymph node biopsy for ocular adnexal melanoma

open access: yesActa ophthalmologica, 2017
Margaret L. Pfeiffer   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy